9 April 2014
Identified a new possible target to combat muscle wasting
Researchers headed by Antonio Zorzano at IRB demonstrate that the DOR protein promotes muscle mass loss in mice.
The scientists hypothesize that the design of an inhibitor against DOR would serve to prevent and tackle muscle wasting in patients suffering from sarcopenia and cachexia.
8 April 2014
IRB moves to "Recerca en directe" fair
Scientists will explain over three days how cancer is studied to the general public.
1 April 2014
Joan Guinovart awarded the prestigious Creu de Sant Jordi
The prize is one of the highest recognitions in Catalonia.
The IRB director is one of 27 individuals and 15 organizations honoured this year.
27 March 2014
Researchers at IRB discover a key regulator of colon cancer
The team headed by Angel Rodríguez Nebreda, ICREA researcher at IRB, identifies for the first time in mice that the p38 MAPK protein is required for the survival and proliferation of colon cancer cells.
In the same study the scientists demonstrate that a p38 inhibitor that has been used in clinical trials for inflammatory diseases shrinks the tumours in mice.
The study, published today in Cancer Cell, has received funding from the BBVA Foundation, the European project InflaCare, the Spanish Government, and the European Research Council (ERC).
21 March 2014
A study using Drosophila flies reveals new regulatory mechanisms of cell migration
The study by Sofia J. Araújo sheds light on the fields of development, wound healing, angiogenesis, and tumour invasion, processes in which cell migration is crucial.
19 March 2014
Two secondary school research projects done at IRB receive awards from the ďRecerca a SecundŗriaĒ Programme
Promoted by the Barcelona Science Park and the Catalunya-La Pedrera Foundation, the programme allows baccalaureate students to do the practical work for their research projects in labs at the Park.
The IRB PhD students Benjamí Oller and Enrique Arenas have tutored the awardees.
6 March 2014
Protein reelin rescues cognitive impairment in animal models of Alzheimerís disease
The study describes the neuroprotective effect of reelin in neurodegenerative diseases.
Co-directed by Eduardo Soriano and Lluís Pujadas, from the University of Barcelona, and the CIBERNED network, the study has involved Bernat Serra-Vidal, Ernest Giralt and Natàlia Carulla, all three scientists at IRB.
5 March 2014
IRB to develop an innovation project on bone metastasis
ICREA researcher Roger Gomis at IRB receives technology valorisation funding from the Generalitat de Catalunya.
This funding seeks to faciliatate the success of technology transfer to the market.
27 February 2014
Researchers reveal the dual role of brain glycogen
Two articles produced by Joan Guinovart’s lab answer key questions regarding the activity of glycogen in neurons.
An excess of glycogen causes neuronal death while a lack of this polysaccharide endangers these cells under oxygen shortage to the brain.
24 February 2014
A step closer to putting together the vital puzzle of the bacteria Escherichia coli
E. coli is the best known model organism at the molecular level. It is used extensively for biotechnology production, and its infectious strains are of biomedical interest.
The article in Nature Biotecnology is a collaborative effort between biologists, biochemists and bioinformaticians at the Craig Venter Institute, the University of Virginia, and the Institute for Research in Biomedicine (IRB).
The team of 18 researchers presents the first map of key interactions between the molecular components of the bacteria, and allow us to understand how its most intimate machinery works.